Tradefest logo
Aseptic Processing in the Manufacture of Biotech and Pharmaceutical

Aseptic Processing in the Manufacture of Biotech and Pharmaceutical 2025

0 / 5

(0 reviews)

Tuesday, June 14, 2022 (1 day), San Jose, United States

Leave a review

Overview

Date: Jun 14, 2022 (1 day)

Venue 6201 America Center Drive, San Jose, CA 95002, USA, San Jose, United States

Organizer ComplianceOnline

Sterile products may be broadly classified into two main categories based on their production mode -- those that are terminally sterilized following the filling and sealing of the container and those that are aseptically sterilized, that is, filter sterilized as a bulk product, filled, and then sealed. Aseptic Processing play a critical role with large molecules that cannot be terminally sterilized. The verification of the process to produce sterile product is evaluated through the demonstration of various media fill process simulations that will vary in both numbers and size of the containers as well as the volumes filled over a defined period. Aseptic Processing involves risk assessment o...n an on-going basis because of the inherent risks due to consequences of management and process failure and challenges within the detection, isolation, control, and management of product contamination. Within aseptic processing, the severity of the consequences of a failure can be severe to the end user while detection through sterility testing remains rather limited because of the small number of final products tested. The FDA and EMA require that any product that may be terminally sterilized be managed in that fashion. However, almost all large molecules and some small molecules can only be sterilized by aseptic processes, i.e., membrane filtration. With membrane filtration, it is essential to establish acceptable levels of microbiological contamination to ensure both product safety and compliance. Meeting sterility claims for Phase 1, 2, 3 and commercial products in a timely and effective manner is important in avoiding costly delays. In addition, since aseptic processes are associated with endotoxin control, it too, must be managed to acceptable levels. A variety of variables can impact sterility assurance and the accompanying endotoxin level. These include the personnel, process, equipment, components, sterilization, depyrogenation as well as facilitates and utilities that impact the management and processing of the ultimate products. Issues that need to be considered include the monitoring of environmental areas and personnel, water sources, media, and media fills, gowning and sanitization. Products that have historically been aseptically filled have relied upon the use of USP <71> Sterility Tests to demonstrate sterility. However, since no more than 20 containers are tested per media (TSB and FTM) regardless of the production lot size, the use of sterility tests does not provide a high degree of sterility assurance (SAL). Thus, media fills are now utilized to simulate the actual fills and to demonstrate at least a 10-3 sterility assurance level of no contamination. If the facility uses RABS or isolators to meet their filling requirements, a SAL of 10-5 to 10-6 is possible since the interactions with personnel and the environment decrease markedly. Media fills are required during the commissioning of an aseptic operation within a new facility, when a new container configuration (volume or neck size) or other unique activities associated with aseptic filling occur. Following the on-going performance of a new aseptic filling line, a requalification is required at six-month intervals. The objective of this live, interactive training seminar is to explore the role of aseptic filling to assure that manufactured product will retain the sterility assurance level prescribed by GMPs. It will review the issues regarding preparing media and setting up the “filtration train”, environmental monitoring, interruptions that may occur during the operation of the Clean Room (planned and unplanned) and the cleaning of the room and its equipment. Equipment used to monitor the equipment and personnel will also be reviewed along with gowning issues that periodically arise. The seminar will also discuss media failures and how to “work through” them. Because of the sensitivity and importance of media fills, this live, interactive training seminar is a MUST for anyone in your organization that is involved in aseptic filling in general and media fills in particular. Please plan to attend this as part of an interactive group project. Read more

Reviews and ratings

Should you go to Aseptic Processing in the Manufacture of Biotech and Pharmaceutical ? Read verified reviews by Tradefest members to help you decide.

Leave a review

No reviews yet. Write the first!

Leave a review

Attendees

See who's going to Aseptic Processing in the Manufacture of Biotech and Pharmaceutical

No attendees registered yet. Be the first!

Similar events

You might be interested in events in the same industries as Aseptic Processing in the Manufacture of Biotech and Pharmaceutical

  • The Art and Science of DentistryThe Art and Science of Dentistry
    The Art and Science of Dentistry

    May 16, 2024 to May 18, 2024

    Anaheim Convention Center, Anaheim, United States

    #Medical Practice#Pharmaceuticals
  • ACHEMAACHEMA

    Jun 10, 2024 to Jun 14, 2024

    Messe Frankfurt, Frankfurt am Main, Germany

Example of a booth at a tradeshow

Need a custom trade show booth?

Speak to the best trade show booth design companies

Get a quote

Copyright © 2024 Tradefest.